DOBUTAMINA HAMELN 12.5mg/ml 125mg / ml perfusive solution concentrate medication leaflet

C01CA07 dobutamine • Cardiovascular system | Cardiac stimulants excluding cardiac glycosides | Adrenergic and dopaminergic agents

Dobutaminum is a medication used for the treatment of acute heart failure and other conditions requiring increased cardiac contractility. It is a beta-adrenergic agonist that stimulates the heart to pump blood more efficiently.

The medication is administered intravenously, usually in a hospital setting, under medical supervision. It is effective in improving cardiac function and stabilizing patients with severe heart failure.

Side effects may include tachycardia, high blood pressure, nausea, and, in rare cases, arrhythmias. Close monitoring of cardiac function is essential during treatment.

Consult your doctor to discuss the benefits and risks of treatment with Dobutaminum. This medication must be administered exclusively in controlled environments, such as hospitals.

General data about DOBUTAMINA HAMELN 12.5mg/ml 125mg / ml

Substance: dobutamine

Date of last drug list: 01-10-2021

Commercial code: W68021003

Concentration: 125mg / ml

Pharmaceutical form: perfusive solution concentrate

Quantity: 10

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: SIEGFRIED HAMELN GMBH - GERMANIA

Holder: HAMELN PHARMA GMBH - GERMANIA

Number: 14039/2021/03

Shelf life: 3 years-after packing for marketing;dupa diluare-it is used immediately

Pharmaceutical forms available for dobutamine

Concentrations available for dobutamine

12.5mg/ml, 125mg/ml, 250mg, 250mg/20ml, 250mg/50ml, 5mg/ml